$BNTXBioNTech SE

Active trials

• phase2A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy Peoplecompletedn=1,353
• phase3Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancerrecruitingn=1,580
• phase1A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIVrecruitingn=67
• phase3A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Childrencompletedn=4,338
• phase2A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancerrecruitingn=105
• phase1Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancerrecruitingn=320
• phase3A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1recruitingn=350
• phase3A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancerrecruitingn=480